Directory
>
Richard Heyman
Richard Heyman
Chairperson of the Board | ARCH Venture Partners
Encinitas, California, United States
Richard Heyman
Summary
Richard Heyman is a seasoned executive in the pharmaceutical and biotechnology sectors, currently serving as the Vice Chairman of the Board of Trustees at the Salk Institute for Biological Studies. With a PhD in Pharmacology from the University of Minnesota, he has accumulated extensive experience in drug discovery and development, particularly in oncology and biochemistry. His leadership roles span various organizations, including chair positions at multiple biotech firms and participation in scientific advisory boards. Richard's career reflects a commitment to advancing life sciences and a passion for innovation in drug development. He is known for his strategic vision and ability to foster collaboration between scientific research and commercial applications. His contributions extend beyond corporate leadership to community engagement, advocating for scientific research and education. Richard's unique blend of scientific expertise and executive experience positions him as a key influencer in the biotech landscape.
Richard Heyman
Work Experience
Chairperson of the Board at
RayzeBio
January 2022 - Present
Board of Director and Scientific Advisory Board Member at
Curebound
January 2021 - Present
Chairman of the Board at
Pharmaceuticals Indevus
January 2020 - Present
BOD Member/Chairman at
Enliven Therapeutics
January 2020 - Present
Venture Partner at
ARCH Venture Partners
January 2020 - Present
Board of Managers at
Life Science Cares Boston
January 2020 - Present
Chairman/BOD member at
Vividion Therapeutics, Inc.
January 2018 - Present
Vice Chairman of The Board of Trustees at
Salk Institute for Biological Studies
August 2015 - Present
Chairman of the BOD at
ORIC Pharmaceuticals Inc.
November 2014 - Present
Executive Chairman at
METACRINE, PTY LTD
June 2015 - January 2022
Chairperson of the Board at
Amunix Pharmaceutical, Inc.
January 2019 - January 2021
BOD Member at
Gritstone bio
November 2015 - January 2021
BOD Member at
Kineta
April 2016 - January 2021
President and CEO at
Seragon Pharmaceuticals
August 2013 - April 2015
President and CEO at
Aragon Pharmaceuticals
May 2009 - August 2013
Chief Scientific Officer at
Kalypsys LLC
January 2006 - January 2008
CSO at
X-Ceptor Therapeutics, Inc.
January 1999 - January 2006
Sr. Vice President at
Exelixis
January 2004 - January 2006
VP Research at
Ligand Pharmaceuticals
January 1990 - January 1999
Postdoctoral Fellow at
Salk Institute for Biological Studies
January 1986 - January 1990
Richard Heyman
Education
University of Minnesota, Phd
January 1980 - January 1986
Frequently Asked Questions about Richard Heyman
What is Richard Heyman email address?
Richard Heyman's primary email address is *******@salk.edu. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Richard Heyman work for?
Richard Heyman is a Chairperson of the Board at ARCH Venture Partners, a company specializing in Short-term business credit.
Where Richard Heyman graduated from?
Richard Heyman holds a degree in Pharmacology from University of Minnesota.
How can I directly contact Richard Heyman?
To contact Richard Heyman directly, you can use the email address *******@salk.edu. Complete contact information is available upon registration with Muraena.
Who is Richard Heyman?
Richard Heyman is a seasoned executive in the pharmaceutical and biotechnology sectors, currently serving as the Vice Chairman of the Board of Trustees at the Salk Institute for Biological Studies. With a PhD in Pharmacology from the University of Minnesota, he has accumulated extensive experience in drug discovery and development, particularly in oncology and biochemistry. His leadership roles span various organizations, including chair positions at multiple biotech firms and participation in scientific advisory boards. Richard's career reflects a commitment to advancing life sciences and a passion for innovation in drug development. He is known for his strategic vision and ability to foster collaboration between scientific research and commercial applications. His contributions extend beyond corporate leadership to community engagement, advocating for scientific research and education. Richard's unique blend of scientific expertise and executive experience positions him as a key influencer in the biotech landscape.
Richard`s contact details
*******@salk.edu
*******@gritstoneoncology.com
Colleagues
Board Member
Venture Partner